Alvine Pharmaceuticals
A biotechnology company focused on the development of therapeutics for the treatmjent of autoimmune and inflammatory diseases
5
Funding Rounds
$147.5m
Money raised
Overview
A biotechnology company focused on the development of therapeutics for the treatmjent of autoimmune and inflammatory diseases
- Website:
- Business model: B2B
| Name | Phone | Social networks | |
|---|---|---|---|
| Ch***** S. Kh**** | - | - | - |
Funding
Funding series
Funding Series Analysis
The company Alvine Pharmaceuticals has raised a total of $104.5m in funding over 5 rounds.
Key Insights:
- Alvine Pharmaceuticals funding round, May 2013: $70m
- Alvine Pharmaceuticals funding round, March 2011: $26.5m
- Alvine Pharmaceuticals Series A round: $8m
- ALVINE PHARMACEUTICALS INC funding round, September 2009: $21.5m
- Alvine Pharmaceuticals Series A round, September 2006: $21.5m
Alvine Pharmaceuticals funding round, May 2013
$70m
Alvine Pharmaceuticals funding round, March 2011
$26.5m
Alvine Pharmaceuticals Series A round
$8m
ALVINE PHARMACEUTICALS INC funding round, September 2009
$21.5m
Alvine Pharmaceuticals Series A round, September 2006
$21.5m
Industries
Alvine Pharmaceuticals is active in the following industries: